Activating Beige Fat

An innate immune pathway stimulates the activity of heat-producing adipose tissue in mice.

Written byKerry Grens
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, BIGPLANKTONThe ability of beige fat tissue to burn energy by producing heat has made it an appealing target for a potential obesity therapy. In studies to find out what turns on these calorie-chewing cells, two independent teams ended up converging upon the same innate immune pathway. Their papers, published today (June 5) in Cell, demonstrate that beige fat activation relies upon the signaling of particular interleukins and the activation of adipose tissue macrophages.

“The big surprise is that there’s an immune pathway that regulates thermogenesis,” said Peter Tontonoz, who studies lipid signaling at the University of California, Los Angeles, and who did not participate in the research. “[This is] a new function for the innate immune system beyond pathogen response.”

Beige fat is an energy-burning form of adipose tissue embedded in white fat, the energy-storing kind. It’s similar to brown fat, which also burns calories, but beige and brown fat have different cellular lineages. Both are not typically abundant in adult humans, and scientists are pursuing the idea that “browning” or “beiging” white adipose tissue—essentially, turning white fat into beige fat—in obese people could help them shed weight.

It’s known that cold exposure can stimulate the production of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies